Table 2.
CYP2C19 genotype (N=100) | 7-day plus probiotics (N=25) | 7-day plus placebo (N=25) |
14-day plus probiotics (N=25) | 14-day plus placebo (N=25) |
---|---|---|---|---|
PM (N=13; 13%) | 3 (66.67%) | 3 (100%) | 3 (100%) | 4 (100%) |
IM No. (N=50; 50%) | 10 (90%) | 11 (81.81%) | 15 (93.33%) | 14 (78.57%) |
RM No. (N=37; 37%) | 12 (58.33%) | 11 (72.72%) | 7 (100%) | 7 (100%) |
*number in parentheses are eradication rates